News & Stories

The Hong Kong University of Science and Technology (HKUST) has shone in the second round of Research, Academic and Industry Sectors One-plus (RAISe+) Scheme launched by Innovation and Technology Commission’s (ITC), securing grants for seven teams – the highest number among local institutions.  The seven funded projects encompass a diverse array of innovative research and development efforts. Three projects focus on health and medical innovation, addressing areas spanning diagnostics, medical treatment and gene therapy.  Three others focus on AI chips, semiconductors and their materials, while the remaining one explores novel displays and optoelectronic technology.

The Hong Kong University of Science and Technology (HKUST) Provost Prof. Yike GUO has been named "Leader of the Year 2024" in the Education/Professional/Technology and Innovation category from Sing Tao News Corporation for his transformative contributions to education and technological innovation in Hong Kong. The award ceremony, held last Friday, was graced by Mr. Paul CHAN, Financial Secretary of the Hong Kong SAR Government, as the Guest of Honor. The event celebrated outstanding leaders across five categories for their significant contributions to Hong Kong’s development.

The Hong Kong University of Science and Technology (HKUST) has emerged as the top-performing local institution in the second round of the Innovation and Technology Commission’s (ITC) Research, Academic and Industry Sectors One-plus (RAISe+) Scheme, securing funding for seven projects. Spanning health and medical sciences, artificial intelligence (AI) and robotics, advanced manufacturing, and electrical and electronic engineering, these projects underscore HKUST’s leadership in transforming pioneering research into real-world applications.

Nearly 1,300 global investors, industry leaders and government and academia representatives from over a dozen countries converged at The Hong Kong University of Science and Technology (HKUST) for Unicorn Day – now one of the largest entrepreneurial events in Hong Kong’s higher education sector. Attendees explored partnerships and exchanged ideas to drive innovation. 

The Hong Kong University of Science and Technology (HKUST) announced today that  its School of Engineering researchers have developed Mixture of Modality Experts (MOME), a groundbreaking large artificial intelligence (AI) model for non-invasive breast cancer diagnosis. Trained on the China’s largest multiparametric MRI (mpMRI) breast cancer dataset, MOME achieves expert-level accuracy in classifying tumor malignancy, comparable to that of radiologists with five+years of experience. This innovative solution is now undergoing extensive clinical validation across more than ten hospitals and partner institutions, including Shenzhen People’s Hospital, the Guangzhou First Municipal People's Hospital, and Yunnan Cancer Center, to validate its effectiveness and ensure real-world applicability. Harnesses China’s largest mpMRI Dataset

The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today.  As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for hundreds of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.  

Two healthtech innovators nurtured by The Hong Kong University of Science and Technology (HKUST) - PanopticAI Limited (PanopticAI) and SmartCare Technology Co Limited (SmartCare), have entered a landmark collaboration with Gleneagles Hospital Hong Kong (Gleneagles). Witnessed by Prof. Nancy IP, President of HKUST; Dr. Prem Kumar NAIR, Group Chief Executive Officer of IHH Healthcare; and Dr. Patrick LAU, Deputy Executive Director of Hong Kong Trade Development Council (HKTDC), the tripartite collaboration agreement signing marks a strategic effort to deploy AI-powered smart clinic solutions at Gleneagles MediCentre, set to launch in late 2025. The partnership exemplifies the commitment of both HKUST and Gleneagles to translating research excellence into real-world applications with a view to facilitating healthcare advancements through the University’s robust entrepreneurship ecosystem.

Pursuing undergraduate studies in Hong Kong 15 years ago marked the start of a highly rewarding journey for Malaysian native Dr. Nick CHIN Jing-Wei. He not only realized his dream of establishing a technology start-up, but also set up his own family here.